Abstract
After reading this chapter, you should know the answers to these questions:
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
http://www.amia.org/applications-informatics/translational-bioinformatics (Accessed 30/11/2012).
- 2.
http://aspe.hhs.gov/admnsimp/pl104191.htm (Accessed 30/11/2012).
- 3.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=11 (Accessed 30/11/2012).
- 4.
http://dictionary.reference.com/browse/genome (Accessed 30/11/2012).
- 5.
AMIA is the American Medical Informatics Association, Bethesda, MD: http://www.amia.org
- 6.
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-06-002.html (Accessed 30/11/2012).
- 7.
http://wiki.hl7.org/index.php?title=CG (Accessed 12/3/2012).
- 8.
http://www.geneontology.org/GO.tools.shtml#alphabet (Accessed 12/3/2012).
- 9.
http://humanparalogy.gs.washington.edu/structuralvariation/general/intro.html (Accessed 12/3/2012).
- 10.
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html (Accessed 12/6/2012).
- 11.
http://www.wellcome.ac.uk/ (Accessed 12/6/2012).
- 12.
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html (Accessed 12/6/2012).
- 13.
http://cancergenome.nih.gov/ (Accessed 12/6/2012).
- 14.
https://www.wtccc.org.uk/index.shtml (Accessed 12/6/2012).
- 15.
http://www.personalgenomes.org/ (Accessed 12/6/2012).
- 16.
http://www.snpedia.com/index.php/SNPedia (Accessed 12/6/2012).
- 17.
https://github.com/xwu/trait-o-matic/wiki (Accessed 12/19/2012).
- 18.
http://www.jsonline.com/news/milwaukee/120091754.html (Accessed 12/21/12).
- 19.
- 20.
http://www.decode.com/research/ (Accessed 12/6/2012).
- 21.
- 22.
https://www.23andme.com/health/BRCA-Cancer/ (Accessed 12/19/12).
References
Alecu, I., Bousquet, C., Mougin, F., & Jaulent, M. C. (2006). Mapping of the WHO-ART terminology on Snomed CT to improve grouping of related adverse drug reactions. Studies in Health Technology and Informatics, 124, 833–838.
Altman, R. B. (2007). PharmGKB: A logical home for knowledge relating genotype to drug response phenotype. Nature Genetics, 39, 426.
Altshuler, D. M., Durbin, R. M., & Genomes Project Consortium. (2010a). A map of human genome variation from population-scale sequencing. Nature, 467, 1061–1073.
Altshuler, D. M., Gibbs, R. A., Peltonen, L., et al. (2010b). Integrating common and rare genetic variation in diverse human populations. Nature, 467, 52–58.
Angrist, M. (2010). Here is a human being: At the dawn of personal genomics. New York: Harper.
Aronson, A.R. (2001). Effective mapping of biomedical text to the UMLS metathesaurus: the MetaMap program. Proceedings of AMIA Symposium, 17–21.
Aronson, A. R., & Lang, F. M. (2010). An overview of MetaMap: Historical perspective and recent advances. Journal of the American Medical Informatics Association: JAMIA, 17, 229–236.
Aronson, A.R., Mork, J.G., Neveol, V., Shooshan, S.E., & Demner-Fushman, D. (2008). Methodology for creating UMLS content views appropriate for biomedical natural language processing. AMIA Annual Symposium Proceedings, 21–25.
Ashburner, M., Ball, C. A., Blake, J. A., et al. (2000). Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nature Genetics, 25, 25–29.
Ashley, E. A., Butte, A. J., Wheeler, M. T., et al. (2010). Clinical assessment incorporating a personal genome. The Lancet, 375, 1525–1535.
Atkinson, A. J., Colburn, W. A., DeGruttola, V. G., et al. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*. Clinical Pharmacology and Therapeutics, 69, 89–95.
Barabasi, A. L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: A network-based approach to human disease. Nature Reviews Genetics, 12, 56–68.
Becker, K. G., Barnes, K. C., Bright, T. J., & Wang, S. A. (2004). The genetic association database. Nature Genetics, 36, 431–432.
Bodenreider, O. (2004). The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Research, 32, D267–D270.
Bradley, W. G., Golding, S. G., Herold, C. J., et al. (2011, August 27–29). Globalization of P4 medicine: Predictive, personalized, preemptive, and participatory–summary of the proceedings of the Eighth International Symposium of the International Society for Strategic Studies in Radiology. Radiology, 258, 571–582.
Brinkman, R. R., Courtot, M., Derom, D., et al. (2010). Modeling biomedical experimental processes with OBI. Journal of Biomedical Semantics, 1(Suppl 1), S7.
Brown, E. G., Wood, L., & Wood, S. (1999). The medical dictionary for regulatory activities (MedDRA). Drug Safety, 20, 109–117.
Bruls, T., & Weissenbach, J. (2011). The human metagenome: Our other genome? Human Molecular Genetics, 20(R2), R142–R148.
Butte, A. J. (2008a). Medicine. The ultimate model organism. Science, 320(5874), 325–327.
Butte, A. J. (2008b). Translational bioinformatics: Coming of age. Journal of the American Medical Informatics Association: JAMIA, 15, 709–714.
Butte, A. (2009). Bioinformatic and computational analysis for genomic medicine. In G. S. Ginsburg & H. F. Willard (Eds.), Essentials of genomic and personalized medicine. Burlington: Elsevier.
Butte, A.J., & Chen, R. (2006). Finding disease-related genomic experiments within an international repository: first steps in translational bioinformatics. AMIA Annual Symposium Proceedings, 106–110.
Camon, E., Magrane, M., Barrell, D., et al. (2003). The gene ontology annotation (GOA) project: Implementation of GO in SWISS-PROT, TrEMBL, and InterPro. Genome Research, 13, 662–672.
Campillos, M., Kuhn, M., Gavin, A. C., et al. (2008). Drug target identification using side-effect similarity. Science, 321, 263–266.
Cedar, H. (1988). DNA methylation and gene activity. Cell, 53, 3–4.
Chan, I. S., & Ginsburg, G. S. (2011). Personalized medicine: Progress and promise. Annual Review of Genomics and Human Genetics, 12, 217–244.
Chan, E. Y., Qian, W. J., Diamond, D. L., et al. (2007). Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: Dysregulated cell cycle progression and nuclear transport coincide with robust virus production. Journal of Virology, 81, 7571–7583.
Choi, M., Scholl, U. I., Ji, W., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 19096–19101.
Church, G., Heeney, C., Hawkins, N., et al. (2009). Public access to genome-wide data: Five views on balancing research with privacy and protection. PLoS Genetics, 5, e1000665.
Cirulli, E. T., & Goldstein, D. B. (2010). Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nature Reviews Genetics, 11, 415–425.
Cook-Deegan, R. (2012). Personal communication.
Coulet, A., Shah, N. H., Garten, Y., et al. (2010). Using text to build semantic networks for pharmacogenomics. Journal of Biomedical Informatics, 43, 1009–1019.
Crick, F. (1970). Central dogma of molecular biology. Nature, 227, 561–563.
Davies, K. (2008). Keeping score of your sequence. BioIT World, 7, 16–21.
Denny, J. C., Ritchie, M. D., Basford, M. A., et al. (2010). PheWAS: Demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics, 26, 1205–1210.
Dewey, F. E., Chen, R., Cordero, S. P., et al. (2011). Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genetics, 7, e1002280.
Donley, G., Hull, S. C., & Berkman, B. E. (2012). Prenatal whole genome sequencing. The Hastings Center Report, 42, 28–40.
Du, X., Callister, S. J., Manes, N. P., et al. (2008). A computational strategy to analyze label-free temporal bottom-up proteomics data. Journal of Proteome Research, 7, 2595–2604.
Dunham, I., Kundaje, A., Aldred, S. F., et al. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414), 57–74.
Edgar, R., Domrachev, M., & Lash, A. E. (2002). Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research, 30, 207–210.
Frueh, F. W., & Gurwitz, D. (2004). From pharmacogenetics to personalized medicine: A vital need for educating health professionals and the community. Pharmacogenomics, 5, 571–579.
Gamazon, E. R., Huang, R. S., Cox, N. J., & Dolan, M. E. (2010). Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proceedings of the National Academy of Sciences of the United States of America, 107, 9287–9292.
Garten, Y., & Altman, R. B. (2009). Pharmspresso: A text mining tool for extraction of pharmacogenomic concepts and relationships from full text. BMC Bioinformatics, 10(Suppl 2), S6.
Garten, Y., Coulet, A., & Altman, R. B. (2010). Recent progress in automatically extracting information from the pharmacogenomic literature. Pharmacogenomics, 11, 1467–1489.
Ge, D., Ruzzo, E. K., Shianna, K. V., et al. (2011). SVA: Software for annotating and visualizing sequenced human genomes. Bioinformatics, 27, 1998–2000.
Ghazvinian, A., Noy, N. F., & Musen, M. A. (2009). Creating mappings for ontologies in biomedicine: Simple methods work. AMIA Annual Symposium Proceedings, 2009, 198–202.
Ghazvinian, A., Noy, N. F., & Musen, M. A. (2011). How orthogonal are the OBO foundry ontologies? Journal of Biomedical Semantics, 2(Suppl 2), S2.
Ginsburg, G. S., & Willard, H. F. (2009). Genomic and personalized medicine: Foundations and applications. Translational Research, 154, 277–287.
Goetz, T. (2010). Sergey Brin’s search for a Parkinson’s cure. Wired, June 22
Goh, K. I., Cusick, M. E., Valle, D., et al. (2007). The human disease network. Proceedings of the National Academy of Sciences of the United States of America, 104, 8685–8690.
Green, R. C., Roberts, J. S., Cupples, L. A., et al. (2009). Disclosure of APOE genotype for risk of Alzheimer’s disease. The New England Journal of Medicine, 361, 245–254.
Gregory, S. (2011). Personal communication.
Hansen, N. T., Brunak, S., & Altman, R. B. (2009). Generating genome-scale candidate gene lists for pharmacogenomics. Clinical Pharmacology and Therapeutics, 86, 183–189.
Heikamp, K., & Bajorath, J. (2011). Large-scale similarity search profiling of ChEMBL compound data sets. Journal of Chemical Information and Modeling, 51, 1831–1839.
Hoffman, M. A. (2007). The genome-enabled electronic medical record. Journal of Biomedical Informatics, 40, 44–46.
Homerova, D., Sprusansky, O., Kutejova, E., & Kormanec, J. (2002). Some features of DNA-binding proteins involved in the regulation of the Streptomyces aureofaciens gap gene, encoding glyceraldehyde-3-phosphate dehydrogenase. Folia Microbiologica (Praha), 47, 311–317.
Hood, L., & Friend, S. H. (2011). Predictive, personalized, preventive, participatory (P4) cancer medicine. Nature Reviews. Clinical Oncology, 8, 184–187.
Hsi-Yang Fritz, M., Leinonen, R., Cochrane, G., & Birney, E. (2011). Efficient storage of high throughput DNA sequencing data using reference-based compression. Genome Research, 21, 734–740.
Hudson, K. L., Holohan, M. K., & Collins, F. S. (2008). Keeping pace with the times–the Genetic Information Nondiscrimination Act of 2008. The New England Journal of Medicine, 358, 2661–2663.
Imai, K., Kricka, L. J., & Fortina, P. (2011). Concordance study of 3 direct-to-consumer genetic-testing services. Clinical Chemistry, 57(3), 518–521.
Irwin, J. J., & Shoichet, B. K. (2005). ZINC–a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45, 177–182.
Jonquet, C., Musen, M. A., & Shah, N. H. (2010). Building a biomedical ontology recommender web service. Journal of Biomedical Semantics, 1(Suppl 1), S1.
Jonquet, C., LePendu, P., Falconer, S., Coulet, A., Noy, N. F., Musen, M. A., & Shah, N. H. (2011). NCBO resource index: Ontology-based search and mining of biomedical resources. Journal of Web Semantics: Science, Services and Agents on the World Wide Web, 9(3), 316–324.
Joshi-Tope, G., Gillespie, M., Vastrik, I., et al. (2005). Reactome: A knowledgebase of biological pathways. Nucleic Acids Research, 33, D428–D432.
Kang, M. J., Lee, C. G., Cho, S. J., et al. (2006). IFN-gamma-dependent DNA injury and/or apoptosis are critical in cigarette smoke-induced murine emphysema. Proceedings of the American Thoracic Society, 3, 517–518.
Keiser, M. J., Setola, V., Irwin, J. J., et al. (2009). Predicting new molecular targets for known drugs. Nature, 462, 175–181.
Khatri, P., & Draghici, S. (2005). Ontological analysis of gene expression data: Current tools, limitations, and open problems. Bioinformatics, 21, 3587–3595.
Kho, A. N., Pacheco, J. A., Peissig, P. L., et al. (2011). Electronic medical records for genetic research: Results of the eMERGE consortium. Science Translational Medicine, 3, 79re71.
Kinnings, S. L., Liu, N., Buchmeier, N., et al. (2009). Drug discovery using chemical systems biology: Repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Computational Biology, 5, e1000423.
Knox, C., Law, V., Jewison, T., et al. (2011). DrugBank 3.0: A comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Research, 39, D1035–D1041.
Kraus, V. B., Burnett, B., Coindreau, J., et al. (2011). Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis and Cartilage, 19, 515–542.
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010). A side effect resource to capture phenotypic effects of drugs. Molecular Systems Biology, 6, 343.
Lamb, J. (2007). The connectivity map: A new tool for biomedical research. Nature Reviews Cancer, 7(1), 54–60.
Lamb, J., Crawford, E. D., Peck, D., et al. (2006). The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929–1935.
Lander, E. S., Linton, L. M., Birren, B., et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860–921.
Landrigan, P. J., Trasande, L., Thorpe, L. E., et al. (2006). The National Children’s Study: A 21-year prospective study of 100,000 American children. Pediatrics, 118, 2173–2186.
Lenfant, C. (2003). Shattuck lecture – clinical research to clinical practice – lost in translation? The New England Journal of Medicine, 349, 868–874.
Lependu, P., Musen, M. A., & Shah, N. H. (2011a). Enabling enrichment analysis with the human disease ontology. Journal of Biomedical Informatics, 44(Suppl 1), S31–S38.
LePendu, P., Racunas, S,A., Iyer, S., et al. (2011b). Annotation analysis for testing drug safety signals. The 14th Bio-Ontologies SIG meeting at ISMB 2011, Vienna, Austria.
Lindhurst, M. J., Sapp, J. C., Teer, J. K., et al. (2011). A mosaic activating mutation in AKT1 associated with the Proteus syndrome. The New England Journal of Medicine, 365(7), 611–619.
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007). BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research, 35, D198–D201.
Lunshof, J. E., Bobe, J., Aach, J., et al. (2010). Personal genomes in progress: From the human genome project to the personal genome project. Dialogues in Clinical Neuroscience, 12, 47–60.
Mailman, M. D., Feolo, M., Jin, Y., et al. (2007). The NCBI dbGaP database of genotypes and phenotypes. Nature Genetics, 39, 1181–1186.
Manolio, T. A., Collins, F. S., Cox, N. J., et al. (2009). Finding the missing heritability of complex diseases. Nature, 461, 747–753.
Meckley, L. M., & Neumann, P. J. (2010). Personalized medicine: Factors influencing reimbursement. Health Policy, 94, 91–100.
Miller, G. C., & Britt, H. (1995). A new drug classification for computer systems: The ATC extension code. International Journal of Bio-Medical Computing, 40, 121–124.
Mork, J. G., Bodenreider, O., Demner-Fushman, D., et al. (2010). Extracting Rx information from clinical narrative. Journal of the American Medical Informatics Association: JAMIA, 17, 536–539.
Mort, M., Evani, U. S., Krishnan, V. G., et al. (2010). In silico functional profiling of human disease-associated and polymorphic amino acid substitutions. Human Mutation, 31, 335–346.
Musen, M. A., Noy, N. F., Shah, N. H., et al. (2011). The national center for biomedical ontology. Journal of the American Medical Informatics Association: JAMIA, 18(4), 441–448.
Ng, S. B., Buckingham, K. J., Lee, C., et al. (2010). Exome sequencing identifies the cause of a mendelian disorder. Nature Genetics, 42, 30–35.
Nicolae, D. L., Gamazon, E., Zhang, W., et al. (2010). Trait-associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS. PLoS Genetics, 6, e1000888.
Novack, D. H., Plumer, R., Smith, R. L., et al. (1979). Changes in physicians’ attitudes toward telling the cancer patient. JAMA: The Journal of the American Medical Association, 241, 897–900.
Obeid, J., Gabriel, D., & Sanderson, I. (2010). A biomedical research permissions ontology: Cognitive and knowledge representation considerations. In Proceedings of the 2010 workshop on Governance of Technology, Information and Policies (pp. 9–13). Austin: ACM.
Olson, S. (2007, July/August). Who’s your daddy? The Atlantic.
Ormond, K. E., Wheeler, M. T., Hudgins, L., et al. (2010). Challenges in the clinical application of whole-genome sequencing. Lancet, 375, 1749–1751.
Overington, J. (2009). ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr. Journal of Computer-Aided Molecular Design, 23, 195–198.
Parrish, F., Do, N., Bouhaddou, O., & Warnekar, P. (2006). Implementation of RxNorm as a terminology mediation standard for exchanging pharmacy medication between federal agencies. AMIA Annual Symposium Proceedings, 1057.
Pencina, M. J., D’Agostino, R. B., Sr., D’Agostino, R. B., Jr., & Vasan, R. S. (2008). Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Statistics in Medicine, 27, 157–172; discussion 207–112.
Pollack, A. (2011, July 29). Ruling upholds gene patent in cancer test. The New York Times. New York City: The New York Times Company.
Quake, S. (2011). Personal communication.
Rhee, S. Y., Wood, V., Dolinski, K., & Draghici, S. (2008). Use and misuse of the gene ontology annotations. Nature Reviews Genetics, 9, 509–515.
Ritchie, M. D., Denny, J. C., Crawford, D. C., et al. (2010). Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. American Journal of Human Genetics, 86, 560–572.
Rocca-Serra, P., Brandizi, M., Maguire, E., et al. (2010). ISA software suite: Supporting standards-compliant experimental annotation and enabling curation at the community level. Bioinformatics, 26, 2354–2356.
Ross, D. T., Scherf, U., Eisen, M. B., et al. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics, 24, 227–235.
Rusk, N. (2010). Expanding HapMap. Nature Methods, 7, 780–781.
Sarkar, I. N., Butte, A. J., Lussier, Y. A., et al. (2011a). Translational bioinformatics: Linking knowledge across biological and clinical realms. Journal of the American Medical Informatics Association: JAMIA, 18, 354–357.
Sarkar, U., Karter, A. J., Liu, J. Y., Adler, N. E., Nguyen, R., Lopez, A., et al. (2011b). Social disparities in internet patient portal use in diabetes: Evidence that the digital divide extends beyond access. Journal of the American Medical Informatics Association: JAMIA, 18(3), 318–321.
Saunders, C. J., Miller, N. A., Soden, S. E., et al. (2012). Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Science Translational Medicine, 4(154), 154ra135.
Schadt, E. E. (2012). The changing privacy landscape in the era of big data. Molecular Systems Biology, 8, 612.
Schaefer, C. F., Anthony, K., Krupa, S., et al. (2009). PID: The pathway interaction database. Nucleic Acids Research, 37, D674–D679.
Schwartz, D., & Collins, F. (2007). Medicine. Environmental biology and human disease. Science, 316, 695–696.
Seal, R. L., Gordon, S. M., Lush, M. J., et al. (2011). Genenames.org: The HGNC resources in 2011. Nucleic Acids Research, 39, D514–D519.
Shah, N. H., & Musen, M.A. (2008). UMLS-Query: a perl module for querying the UMLS. AMIA Annual Symposium Proceedings, 652–656.
Shah, N. H., Rubin, D. L., Espinosa, I., et al. (2007). Annotation and query of tissue microarray data using the NCI thesaurus. BMC Bioinformatics, 8, 296.
Shah, N. H., Jonquet, C., Chiang, A. P., et al. (2009a). Ontology-driven indexing of public datasets for translational bioinformatics. BMC Bioinformatics, 10(Suppl 2), S1.
Shah, S. H., Crosslin, D.R., Nelson, S., et al. (2009b). Metabolomic profiles are associated with baseline insulin resistance and improvement in insulin resistance with weight loss in the WLM trial. Ciculation.
Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin, K. (2001). DbSNP: The NCBI database of genetic variation. Nucleic Acids Research, 29, 308–311.
Shortliffe, E. H., Califano, A., & Hunter, L. (2009). New JBI emphasis on translational bioinformatics. Journal of Biomedical Informatics, 42, 199–200.
Shuldiner, A. R., O’Connell, J. R., Bliden, K. P., et al. (2009). Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA: The Journal of the American Medical Association, 302, 849–857.
Singer, E. (2011). A family learns the secrets of its genomes. MIT Technology Review.
Sirota, M., Dudley, J. T., Kim, J., et al. (2011). Discovery and preclinical validation of drug indications using compendia of public gene expression data. Science Translational Medicine, 3, 96ra77.
Sobradillo, P., Pozo, F., & Agusti, A. (2011). P4 medicine: The future around the corner. Archivos de BronconeumologÃa, 47, 35–40.
Spackman, K.A., Campbell, K.E., & Cote, R.A. (1997a). SNOMED RT: a reference terminology for health care. Proceedings of the AMIA Annual Fall Symposium, 640–644.
Spackman, K. A., Campbell, K. E., et al. (1997b). SNOMED-RT: A reference terminology for health care. In D. R. Masys (Ed.), Proceedings, AMIA annual fall symposium (pp. 640–644). Philadelphia: Hanley and Belfus.
Stein, L. D. (2010). The case for cloud computing in genome informatics. Genome Biology, 11, 207.
Stenson, P. D., Mort, M., Ball, E. V., et al. (2009). The human gene mutation database: 2008 update. Genome Medicine, 1, 13.
Steyerberg, E. W., Pencina, M. J., Lingsma, H. F., et al. (2011). Assessing the incremental value of diagnostic and prognostic markers: A review and illustration. European Journal of Clinical Investigation, 42(2), 216–228.
Subramanian, A., Tamayo, P., Mootha, V. K., et al. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 102, 15545–15550.
Sung, N. S., Crowley, W. F., Jr., Genel, M., et al. (2003). Central challenges facing the national clinical research enterprise. JAMA: The Journal of the American Medical Association, 289(10), 1278–1287.
Tarczy-Hornoch, P., Markey, M. K., Smith, J. A., & Hiruki, T. (2007). Bio*medical informatics and genomic medicine: Research and training. Journal of Biomedical Informatics, 40, 1–4.
Tatonetti, N. P., Fernald, G. H., & Altman, R. B. (2011a). A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. Journal of the American Medical Informatics Association: JAMIA, 19(1), 79–85.
Tatonetti, N. P., Denny, J. C., Murphy, S. N., et al. (2011b). Detecting drug interactions from adverse-event reports: Interaction between paroxetine and pravastatin increases blood glucose levels. Clinical Pharmacology and Therapeutics, 90, 133–142.
Taylor, C. F., Field, D., Sansone, S. A., Aerts, J., et al. (2008). Promoting coherent minimum reporting guidelines for biological and biomedical investigations: The MIBBI project. Nature Biotechnology, 26, 889–896.
Tenenbaum, J., James, A., & Paulyson-Nuñez, K. (2012). An altered treatment plan based on direct to consumer (DTC) genetic testing: Personalized medicine from the patient/pin-cushion perspective. Journal of Personalized Medicine, 2(4), 192–200.
Thorisson, G. A., Smith, A. V., Krishnan, L., & Stein, L. D. (2005). The international HapMap project web site. Genome Research, 15, 1592–1593.
Trusheim, M. R., Berndt, E. R., & Douglas, F. L. (2007). Stratified medicine: Strategic and economic implications of combining drugs and clinical biomarkers. Nature Reviews Drug Discovery, 6, 287–293.
Venter, J. C., Adams, M. D., Myers, E. W., et al. (2001). The sequence of the human genome. Science, 291, 1304–1351.
Via, M., Gignoux, C., & Burchard, E. G. (2010). The 1000 genomes project: new opportunities for research and social challenges. Genome Medicine, 2, 3.
Wang, X., Hripcsak, G., Markatou, M., & Friedman, C. (2009a). Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: A feasibility study. Journal of the American Medical Informatics Association: JAMIA, 16(3), 328–337.
Wang, Y., Xiao, J., Suzek, T. O., et al. (2009b). PubChem: A public information system for analyzing bioactivities of small molecules. Nucleic Acids Research, 37, W623–W633.
Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B. A., Suzek, T. O., Wang, J., Xiao, J., Zhang, J., & Bryant, S. H. (2010). An overview of the PubChem BioAssay resource. Nucleic Acids Research, 38, D255–D266.
Waxman, A. B., Einarsson, O., Seres, T., et al. (1999). Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. Chest, 116, 8S–9S.
Weston, A. D., & Hood, L. (2004). Systems biology, proteomics, and the future of health care: Toward predictive, preventative, and personalized medicine. Journal of Proteome Research, 3, 179–196.
Wishart, D. S. (2011). Advances in metabolite identification. Bioanalysis, 3, 1769–1782.
Worthey, E. A., Mayer, A. N., Syverson, G. D., et al. (2011). Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genetics in Medicine, 13(3), 255–262.
WTCCC. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661–678.
Yildirim, M. A., Goh, K. I., Cusick, M. E., et al. (2007). Drug-target network. Nature Biotechnology, 25, 1119–1126.
Zerhouni, E. A. (2006). Clinical research at a crossroads: The NIH roadmap. Journal of Investigative Medicine, 54, 171–173.
Zhu, J., Zhang, B., & Schadt, E. E. (2008). A systems biology approach to drug discovery. Advances in Genetics, 60, 603–635.
Zhu, Q., Ge, D., Maia, J. M., et al. (2011). A genome-wide comparison of the functional properties of rare and common genetic variants in humans. American Journal of Human Genetics, 88, 458–468.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Tenenbaum, J.D., Shah, N.H., Altman, R.B. (2014). Translational Bioinformatics. In: Shortliffe, E., Cimino, J. (eds) Biomedical Informatics. Springer, London. https://doi.org/10.1007/978-1-4471-4474-8_25
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4474-8_25
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4473-1
Online ISBN: 978-1-4471-4474-8
eBook Packages: MedicineMedicine (R0)